Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Senior Management
Scientific Advisory Board
Corporate Governance
Programs
Xolatryp
Myocardial Ischemia and Arrhythmia Control
Stroke
Traumatic Brain Injury
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
ASX Announcements
Filter by Year:
2026
2025
2024
2023
2022
2021
2020
18-Feb-2026
Capital Structure Update
18-Feb-2026
Top 20 CDI Holder List
18-Feb-2026
Nyrada Half Year FY2026 Results
18-Feb-2026
Appendix 4D and Half Year Report to 31 December 2025
5-Feb-2026
Cleansing Statement
5-Feb-2026
Application for quotation of securities - NYR
5-Feb-2026
Investor Update Webinar
5-Feb-2026
Nyrada Phase IIa Clinical Trial Factsheet
29-Jan-2026
Change in substantial holding - Matt Corp WA PL
29-Jan-2026
Change in substantial holding - M Azzi
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
Next
